Department of Neurological Surgery, University of Virginia, Virginia, USA.
Department of Neurological Surgery, University of Miami, Florida, USA.
World Neurosurg. 2019 May;125:e1114-e1124. doi: 10.1016/j.wneu.2019.01.253. Epub 2019 Feb 18.
This study aims to evaluate the outcomes of Gamma Knife stereotactic radiosurgery (SRS) for dural arteriovenous fistulas (dAVFs) in older patients (≥65 years) compared with younger patients (age <65 years).
Two groups with a total of 96 patients were selected from a database of 133 patients with dAVF from 9 international medical centers with a minimum 6 months follow-up. A 1:2 propensity matching was performed by nearest-neighbor matching criteria based on sex, Borden grade, maximum radiation dose given, and location. The older cohort consisted of 32 patients and the younger cohort consisted of 64 patients. The mean overall follow-up in the combined cohort was 42.4 months (range, 6-210 months).
In the older cohort, a transverse sinus location was found to significantly predict dAVF obliteration (P = 0.01). The post-SRS actuarial 3-year and 5-year obliteration rates were 47.7% and 78%, respectively. There were no cases of post-SRS hemorrhage. In the younger cohort, the cavernous sinus location was found to significantly predict obliteration (P = 0.005). The 3-year and 5-year actuarial obliteration rates were 56% and 70%, respectively. Five patients (7.8%) hemorrhaged after SRS. Margin dose ≥25 Gy was predictive of unfavorable outcome. The obliteration rate (P = 0.3), post-SRS hemorrhage rate (P = 0.16), and persistent symptoms after SRS (P = 0.83) were not statistically different between the 2 groups.
SRS achieves obliteration in most older patients with dAVF, with an acceptable rate of complication. There was no increased risk of postradiosurgery complications in the older cohort compared with the younger patients.
本研究旨在评估伽玛刀立体定向放射外科(SRS)治疗老年(≥65 岁)与年轻(<65 岁)患者硬脑膜动静脉瘘(dAVF)的结果。
从 9 个国际医学中心的 133 例 dAVF 患者数据库中选择了两组患者,每组 96 例,随访时间至少 6 个月。根据性别、Borden 分级、最大放射剂量和位置,采用最近邻匹配标准进行 1:2 倾向评分匹配。老年组 32 例,年轻组 64 例。在联合队列中,平均总随访时间为 42.4 个月(范围,6-210 个月)。
在老年组中,横窦位置显著预测 dAVF 闭塞(P=0.01)。SRS 后 3 年和 5 年闭塞率分别为 47.7%和 78%。无 SRS 后出血病例。在年轻组中,海绵窦位置显著预测闭塞(P=0.005)。3 年和 5 年的闭塞率分别为 56%和 70%。5 例(7.8%)患者在 SRS 后出血。边缘剂量≥25 Gy 与不良结局相关。两组间闭塞率(P=0.3)、SRS 后出血率(P=0.16)和 SRS 后持续症状(P=0.83)无统计学差异。
SRS 可使大多数老年 dAVF 患者获得闭塞,并发症发生率可接受。与年轻患者相比,老年患者 SRS 后并发症的风险没有增加。